| scholarly article | Q13442814 |
| review article | Q7318358 |
| P5530 | Altmetric DOI | 10.3390/NU6125679 |
| P6409 | CORE ID | 30341504 |
| P6179 | Dimensions Publication ID | 1033626746 |
| P356 | DOI | 10.3390/NU6125679 |
| P953 | full work available at URL | http://eprints.whiterose.ac.uk/120103/ |
| P3181 | OpenCitations bibliographic resource ID | 1769006 |
| P932 | PMC publication ID | 4276992 |
| P698 | PubMed publication ID | 25514388 |
| P5875 | ResearchGate publication ID | 269773801 |
| P1154 | Scopus EID | 2-s2.0-84916940992 |
| P50 | author | J Bernadette Moore | Q47158643 |
| P2093 | author name string | Barbara Fielding | |
| Pippa Gunn | |||
| P2860 | cites work | Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes. | Q45964397 |
| Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. | Q46442905 | ||
| Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake | Q46473255 | ||
| Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. | Q46570510 | ||
| Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin | Q46659219 | ||
| A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study | Q47312991 | ||
| Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes | Q47915943 | ||
| No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. | Q47969446 | ||
| Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. | Q51330295 | ||
| Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. | Q51343064 | ||
| A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. | Q51483727 | ||
| Effects of carbohydrates on uric acid metabolism | Q54131746 | ||
| Dietary intake of carbohydrates and risk of type 2 diabetes: the European Prospective Investigation into Cancer-Norfolk study | Q57202603 | ||
| Intake of Added Sugar and Sugar-Sweetened Drink and Serum Uric Acid Concentration in US Men and Women | Q58578742 | ||
| Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial | Q61862450 | ||
| Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans | Q62745793 | ||
| Studies of the mechanisms of carbohydrate-induced lipaemia in normal man | Q68662949 | ||
| Hexose infusions in Cebus monkeys: Effects on uric acid metabolism | Q69377801 | ||
| Fructose-induced hyperuricaemia | Q70076003 | ||
| Predictors of non-alcoholic fatty liver disease in obese children | Q79411913 | ||
| Mechanisms for the acute effect of fructose on postprandial lipemia | Q80447618 | ||
| Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study | Q83505457 | ||
| National estimates of dietary fructose intake increased from 1977 to 2004 in the United States | Q83747795 | ||
| Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis | Q84582749 | ||
| The relationship of serum uric acid with non-alcoholic fatty liver disease | Q87287629 | ||
| Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease | Q87521640 | ||
| Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice | Q24306427 | ||
| SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis | Q24310555 | ||
| Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know? | Q24629127 | ||
| Fructose consumption as a risk factor for non-alcoholic fatty liver disease | Q24657933 | ||
| From NAFLD in clinical practice to answers from guidelines | Q27000185 | ||
| Effect of fructose on postprandial triglycerides: a systematic review and meta-analysis of controlled feeding trials. | Q27693224 | ||
| Intermediary metabolism of fructose | Q28255132 | ||
| Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis | Q28260411 | ||
| Fructose induced lipogenesis: from sugar to fat to insulin resistance | Q28298033 | ||
| High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study | Q28474831 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis | Q28508851 | ||
| A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver | Q28583240 | ||
| The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study | Q28728752 | ||
| Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults | Q29614911 | ||
| The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association | Q29617157 | ||
| Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease | Q29619334 | ||
| Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey | Q30572017 | ||
| Clinical research strategies for fructose metabolism | Q33578657 | ||
| Glucose transporter 8 (GLUT8) mediates fructose-induced de novo lipogenesis and macrosteatosis | Q33676162 | ||
| Misconceptions about fructose-containing sugars and their role in the obesity epidemic | Q33833503 | ||
| Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies | Q34035107 | ||
| Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. | Q34056163 | ||
| Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease | Q34069352 | ||
| Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. | Q34091776 | ||
| Metabolic effects of fructose and the worldwide increase in obesity. | Q34093669 | ||
| Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study | Q34113313 | ||
| Measurement of de novo hepatic lipogenesis in humans using stable isotopes | Q34190285 | ||
| The effects of fructose intake on serum uric acid vary among controlled dietary trials. | Q34211386 | ||
| Calorie-sweetened beverages and fructose: what have we learned 10 years later. | Q34341704 | ||
| Very high fructose intake increases serum LDL-cholesterol and total cholesterol: a meta-analysis of controlled feeding trials | Q34355335 | ||
| Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. | Q38022260 | ||
| Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis | Q38064611 | ||
| Dietary fructose in nonalcoholic fatty liver disease | Q38079794 | ||
| Carbohydrate intake and nonalcoholic fatty liver disease | Q38105233 | ||
| Dietary strategies for the management of cardiovascular risk: role of dietary carbohydrates | Q38189860 | ||
| Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements | Q38295025 | ||
| Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. | Q38299514 | ||
| The role of the carbohydrate response element-binding protein in male fructose-fed rats | Q38319892 | ||
| Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes. | Q39175545 | ||
| Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans | Q39821210 | ||
| Comparative effects of fructose and glucose on the lipid and carbohydrate metabolism of perfused rat liver | Q40000632 | ||
| Differences in the metabolism of dietary carbohydrates studied in the rat | Q40007445 | ||
| The Effect of High-Carbohydrate Diets on Liver Triglyceride Formation in the Rat | Q40372926 | ||
| Regulation of rat liver L-type pyruvate kinase mRNA by insulin and by fructose. | Q42256880 | ||
| Fatty acid synthetase activity in the liver and adipose tissue of rats fed with various carbohydrates | Q42918905 | ||
| The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism | Q42924597 | ||
| Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. | Q43059708 | ||
| Effects of a short-term overfeeding with fructose or glucose in healthy young males | Q43237468 | ||
| Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study | Q43979789 | ||
| The global NAFLD epidemic | Q44238213 | ||
| Localization of the carbohydrate response element of the rat L-type pyruvate kinase gene. | Q44264131 | ||
| Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study | Q44451078 | ||
| Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. | Q44552194 | ||
| Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease | Q44664390 | ||
| Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms | Q44832224 | ||
| Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles | Q45011736 | ||
| Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults. | Q45906764 | ||
| Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. | Q34406791 | ||
| Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver | Q34462446 | ||
| Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease | Q34467142 | ||
| The influence of dietary fat on liver fat accumulation. | Q34578071 | ||
| Fructose metabolism in humans - what isotopic tracer studies tell us. | Q34643422 | ||
| Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: a randomized controlled trial | Q34693414 | ||
| The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality | Q34877729 | ||
| Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men | Q34917717 | ||
| Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome | Q35004042 | ||
| Observational research methods. Research design II: cohort, cross sectional, and case-control studies | Q35047744 | ||
| De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals | Q35077618 | ||
| The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. | Q35090215 | ||
| Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis. | Q35139058 | ||
| Consumption of added sugars is decreasing in the United States | Q35163947 | ||
| Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD | Q35523269 | ||
| The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans | Q36005304 | ||
| Omega-3 fatty acid deficiency augments risperidone-induced hepatic steatosis in rats: positive association with stearoyl-CoA desaturase | Q36164661 | ||
| Expanding roles for SREBP in metabolism | Q36303731 | ||
| Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. | Q36418940 | ||
| Hepatic histology in obese patients undergoing bariatric surgery | Q36561289 | ||
| ChREBP, a transcriptional regulator of glucose and lipid metabolism | Q36788526 | ||
| Challenging the fructose hypothesis: new perspectives on fructose consumption and metabolism | Q36829684 | ||
| Dietary sugars stimulate fatty acid synthesis in adults | Q36898127 | ||
| Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver | Q37023053 | ||
| Soft drink consumption linked with fatty liver in the absence of traditional risk factors | Q37141336 | ||
| Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans | Q37170824 | ||
| Ethnic differences in hepatic steatosis: an insulin resistance paradox? | Q37175282 | ||
| Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome | Q37324307 | ||
| Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet | Q37354550 | ||
| Effect on caries of restricting sugars intake: systematic review to inform WHO guidelines | Q37414217 | ||
| Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome | Q37693238 | ||
| A systematic survey of lipids across mouse tissues | Q37707634 | ||
| Cross-regulation of hepatic glucose metabolism via ChREBP and nuclear receptors. | Q37859916 | ||
| Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. | Q37983763 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver disease | Q929737 |
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| human digestive system | Q9649 | ||
| carbohydrate | Q11358 | ||
| non-alcoholic fatty liver | Q66299798 | ||
| physiological phenomenon | Q66615932 | ||
| energy metabolism | Q30225378 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 5679-703 | |
| P577 | publication date | 2014-12-10 | |
| P1433 | published in | Nutrients | Q7070485 |
| P1476 | title | The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease | |
| P478 | volume | 6 |
| Q38761767 | Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity. |
| Q36401194 | Assessment of Diet and Physical Activity in Paediatric Non-Alcoholic Fatty Liver Disease Patients: A United Kingdom Case Control Study |
| Q47739558 | Avian and murine neurosecretory protein GL participates in the regulation of feeding and energy metabolism. |
| Q38937960 | Beverage consumption and paediatric NAFLD. |
| Q38577570 | Caring for children with NAFLD and navigating their care into adulthood |
| Q58600361 | ChREBP Reciprocally Regulates Liver and Plasma Triacylglycerol Levels in Different Manners |
| Q28072381 | Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease |
| Q36678017 | Diet and adipose tissue distributions: The Multi-Ethnic Study of Atherosclerosis |
| Q55050296 | Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein. |
| Q53175596 | Differential modulation of cytosolic lipases activities in liver and adipose tissue by high-carbohydrate diets. |
| Q92636555 | Effect of Nutrient and Micronutrient Intake on Chylomicron Production and Postprandial Lipemia |
| Q42135041 | Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle |
| Q92949881 | Effects of obesity on cholesterol metabolism and its implications for healthy ageing |
| Q91995108 | Energy-dense nutrient-poor snacks and risk of non-alcoholic fattyliver disease: a case-control study in Iran |
| Q53661039 | Excessive consumption of fructose causes cardiometabolic dysfunctions through oxidative stress and inflammation. |
| Q92694745 | From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis |
| Q26801099 | Fructose Metabolism and Relation to Atherosclerosis, Type 2 Diabetes, and Obesity |
| Q26778035 | Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico |
| Q35809069 | Hepatic Steatosis as a Marker of Metabolic Dysfunction. |
| Q38576287 | Isocaloric manipulation of macronutrients within a high-carbohydrate/moderate-fat diet induces unique effects on hepatic lipogenesis, steatosis and liver injury |
| Q37575895 | Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway |
| Q38702671 | LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice |
| Q64326583 | Leucrose, a Sucrose Isomer, Suppresses Hepatic Fat Accumulation by Regulating Hepatic Lipogenesis and Fat Oxidation in High-fat Diet-induced Obese Mice |
| Q39227666 | Liver Fatty Acid Composition and Inflammation in Mice Fed with High-Carbohydrate Diet or High-Fat Diet |
| Q36836003 | Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women |
| Q33604846 | Metabolic Syndrome and Hypertension Resulting from Fructose Enriched Diet in Wistar Rats. |
| Q37294679 | Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats |
| Q58417407 | Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease |
| Q26771241 | Negative, Null and Beneficial Effects of Drinking Water on Energy Intake, Energy Expenditure, Fat Oxidation and Weight Change in Randomized Trials: A Qualitative Review |
| Q91638396 | Neurosecretory Protein GL Induces Fat Accumulation in Chicks |
| Q41364728 | Neurosecretory protein GL stimulates food intake, de novo lipogenesis, and onset of obesity |
| Q38866384 | Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids. |
| Q57283707 | Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria |
| Q37134761 | Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR). |
| Q58800011 | Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways |
| Q28079432 | Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions |
| Q41457655 | Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. |
| Q96774001 | Post-weaning exposure to high-sucrose diet induces early non-alcoholic fatty liver disease onset and progression in male mice: role of dysfunctional white adipose tissue |
| Q38493695 | Relevance of liver fat to the impact of dietary extrinsic sugars on lipid metabolism |
| Q58758323 | Sex Differences in Hepatic Lipogenesis with Acute Fructose Feeding |
| Q38787454 | Sugars and health: a review of current evidence and future policy |
| Q36151024 | The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys |
| Q26744380 | The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background |
| Q50985116 | The effect of early-life stress and chronic high-sucrose diet on metabolic outcomes in female rats. |
| Q90205939 | Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source |
| Q90690372 | Transcriptome signature for dietary fructose-specific changes in rat renal cortex: A quantitative approach to physiological relevance |
| Q56701573 | What Is the Optimal Dietary Composition for NAFLD? |
Search more.